Accolade IPO
Accolade operates a personalized healthcare platform that provides advocacy and navigation services to employees and their families. The company helps people navigate complex healthcare systems through technology and human support, making it attractive to investors focused on the growing healthcare technology sector.
Key Facts
| Industry | Healthcare Services |
| Founded | 2007 |
| Headquarters | Seattle, WA |
| Employees | ~2,000-3,000 |
| Website | accolade.com |
| Funding | Public company (IPO 2020) |
About Accolade
Accolade provides personalized health and benefits navigation services to help employees and their families make better healthcare decisions while reducing costs for employers. The company combines technology platforms with human health assistants and clinicians to guide individuals through complex healthcare systems, from finding appropriate providers to understanding treatment options and managing chronic conditions.
As a publicly traded company since 2020, Accolade serves millions of members through employer partnerships, focusing on improving health outcomes while reducing unnecessary healthcare spending. The company's integrated approach combines advocacy, primary care, mental health services, and benefits administration into a unified platform, positioning it in the growing healthcare consumerism market where employers seek to provide better healthcare experiences while controlling costs.
IPO Status
Accolade went public in July 2020, trading on NASDAQ under the ticker symbol ACCD. The company priced its IPO at $22 per share, raising approximately $220 million. The stock saw significant volatility in its early trading periods, reflecting broader market sentiment around healthcare technology companies. Since going public, Accolade has continued to expand its platform capabilities and customer base. The company serves employers, health plans, and consumers with personalized healthcare guidance and advocacy services, positioning itself in the growing digital health market.
Competitors
Frequently Asked Questions
Does Accolade have a stock?
Yes, Accolade completed its IPO in July 2020. The company went public on NASDAQ under the ticker symbol ACCD.
When is the Accolade IPO date?
Accolade's IPO date was July 2, 2020. The company is already publicly traded, so there is no upcoming IPO date.
How can I buy Accolade stock?
You can buy Accolade stock through any brokerage account since it trades publicly on NASDAQ under the ticker ACCD. The stock is available through major brokers like Fidelity, Charles Schwab, E*TRADE, and others.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts